Friday, May 06, 2016 11:12:11 AM
Posting has slowed down and so has trading. 1 month, 1 week into 2nd Qtr.
As this point, within next 7 weeks therefore, we should expect any or all of the following:
- Filing of dCellVax testing data with response to FDA on behalf of IND
- Update on filing of tCellVax (NR2F6) IND in March
- Possible update on Pan Am Cancer center (next 5 patients) on in human testing of HemaXellerate
- NCATS compound research testing (although some or all of this testing data might just go into the IND research / FDA filings without us knowing whether or not a new IND was based on NCATS or not
- Eli Lilly cooperative as to whether there are any "hits" through that program as well.
Whether any or all of this news will move the PPS up significantly is anyone's guess at this point and depends on company's ability and way of raising funds for ongoing needs.
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM